News

Rhythm Pharmaceuticals Convenes Inaugural International Meeting on Pathway-Related Obesity: Vision of Excellence (IMPROVE) 2022

-- Approximately 100 European health care professionals invited to discuss recent scientific developments in rare pathway-related obesities -- -- Rhythm…

2 years ago

Teladoc Health to Announce Third Quarter 2022 Financial Results

PURCHASE, NY, Oct. 11, 2022 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE: TDOC), the global leader in whole-person virtual care,…

2 years ago

Clearmind Medicine Featured in “Psychedelics Tonight,” Streaming on ALTRD.TV

The first episode, "Psychedelic Novelty - Before it was Cool," introduces the company's proprietary molecule MEAI VANCOUVER, Oct. 11, 2022…

2 years ago

Microbot Medical Enhances Strategic Focus on its Endovascular Solutions

Suspending Development of SCS and Evaluating Alternatives for SCS AssetsHINGHAM, Mass., Oct. 11, 2022 (GLOBE NEWSWIRE) -- Microbot Medical Inc.…

2 years ago

Nextech Announces Acquisition of TouchMD, Enhancing Specialty Practice Patient Experience

TouchMD brings advanced benefits to Nextech clients and their patientsTAMPA, Fla., Oct. 11, 2022 (GLOBE NEWSWIRE) -- Nextech, the market…

2 years ago

Optimi Health Announces Closing of Strategic Non-Brokered Private Placement

Chip Wilson expands current share position and commits gross proceeds of up to $3.27 millionNOT FOR DISTRIBUTION TO U.S. NEWSWIRE…

2 years ago

Accelus Announces New Milestone with Its FlareHawk® Interbody Fusion System Surpassing 15,000 Devices Implanted

FlareHawk Expandable Lumbar Interbody Fusion System Accelus Announces New Milestone with Its FlareHawk® Interbody Fusion System Surpassing 15,000 Devices ImplantedPALM…

2 years ago

Cannabix Technologies to Participate in October Southern US Study using Marijuana Breathalyzer Technology

Cannabix is developing Marijuana Breathalyzer devices to give law enforcement and employers a tool to enhance public safety Cannabix October…

2 years ago

SCYNEXIS to Present Positive Interim Data from the Phase 3 FURI Study of Oral Ibrexafungerp at IDWeek 2022

JERSEY CITY, N.J., Oct. 11, 2022 (GLOBE NEWSWIRE) -- SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company pioneering innovative medicines to…

2 years ago

Tarsus Announces Transition Plans for Board of Directors

Co-founder and Chairman Michael Ackermann plans to transition off Board of Directors Wendy Yarno will become Lead Independent Director and…

2 years ago